Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
about
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaSYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia.Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapyEfficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing ProgramClonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapseExcellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocolSurvival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.Autotransplantation for relapsed ALL: going, going, gone?Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.Hydrogen peroxide activation of ERK5 confers resistance to Jurkat cells against apoptosis induced by the extrinsic pathway.Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment.Extramedullary Relapse of Acute Myeloid and Lymphoid Leukemia in Children: A Retrospective Analysis.Reappearance of acute lymphoblastic leukemia 34 years after initial diagnosis: a case report and study of the origin of the reappeared blasts.Outcome of children treated for relapsed acute lymphoblastic leukemia in Central America.The Evolution and Future of CAR T Cells for B-Cell Acute Lymphoblastic Leukemia.Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study.New targeted therapies for relapsed pediatric acute lymphoblastic leukemia.
P2860
Q26781328-DB5F9AA8-D853-40A2-B03B-828B40771EE1Q33631405-1597D3FC-CDE8-4C5D-A1A6-78CF509AFF5CQ34323258-9215E3DE-07A9-4383-9ACE-6501C40240D0Q34543909-07BC1005-563D-4BFB-A1BB-76793FA077E1Q35102275-37965BC9-DD3F-4412-9F34-1B446B9A062DQ36366644-4A6683D6-3B6E-430E-85DB-02B00E825CBDQ36488188-682E9502-79A3-4D82-9AF5-91A54F0594C0Q37900934-64DA6695-00D2-4A29-9CF2-AF18C0B7F2C6Q38097334-D173ABAF-7B31-486E-A8C4-A5B8488D9874Q38604857-1E53D511-28B8-4DDE-AED1-98CBCF705A0CQ38839812-1A2A4359-DE9A-4391-AE60-D3E38B20C04DQ38856941-49CDBC41-A5E0-4A90-AA55-47A0C4414528Q41505498-4C40F6C8-2FF0-47D1-BD23-4CACE490BDD0Q43583327-3745B432-006D-4625-83D8-9DAD58B47948Q45236803-DFCB3E46-EFE4-442B-B9A5-9D42337CA6A2Q47820469-29335860-B789-4F79-9A73-2F60E9EF30EFQ49497206-24E62E18-9BF4-4B76-A1C2-78377729AF01Q51839566-AB7B258B-6410-42E9-B6E8-0D7405153197
P2860
Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Postrelapse survival in childh ...... the Children's Oncology Group.
@ast
Postrelapse survival in childh ...... the Children's Oncology Group.
@en
Postrelapse survival in childh ...... the Children's Oncology Group.
@nl
type
label
Postrelapse survival in childh ...... the Children's Oncology Group.
@ast
Postrelapse survival in childh ...... the Children's Oncology Group.
@en
Postrelapse survival in childh ...... the Children's Oncology Group.
@nl
prefLabel
Postrelapse survival in childh ...... the Children's Oncology Group.
@ast
Postrelapse survival in childh ...... the Children's Oncology Group.
@en
Postrelapse survival in childh ...... the Children's Oncology Group.
@nl
P2093
P2860
P50
P1433
P1476
Postrelapse survival in childh ...... the Children's Oncology Group.
@en
P2093
David R Freyer
Meenakshi Devidas
William L Carroll
P2860
P304
P356
10.1182/BLOOD-2010-07-294678
P407
P577
2010-12-30T00:00:00Z